Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

NCT00191568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin
PROCEDURE: Radiotherapy

Sponsor

Eli Lilly and Company